Application | Comment | Organism |
---|---|---|
medicine | the use of spironolactone and angiotensin-converting enzyme inhibitor combination, in general practice, is largely inappropriate. This could explain an increased incidence of severe hyperkalemia. A risk management plan is needed to obtain a careful selection of patients who derive benefit from therapy and to minimise the risk of hyperkalemia | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |